NEW YORK, July 3, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Mead Johnson Nutrition Company ("Mead Johnson" or the "Company") (NYSE: MJN). The investigation focuses on whether the Company and its executives violated federal securities laws.
July 3, 2013 shares of Mead Johnson fell 8% during intraday trading after multiple media sources reported that the National Development and Reform Commission, China's top economic planning agency,
launched an investigation into foreign infant-formula companies over alleged price fixing violations. The state-run People's Daily reported Tuesday that companies also including U.S.-based Abbott Laboratories, Mead Johnson Nutrition Co., and Dutch-based FrieslandCampina, are under investigation for allegedly violating anti-monopoly laws by charging high prices and limiting competition. According to an analyst at Wells Fargo,
Hong Kong comprise roughly 30% of Mead Johnson's sales.
If you are aware of any facts relating to this investigation, or purchased shares of Mead Johnson you can assist this investigation by contacting either Peretz Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email email@example.com . Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Eitan Kimelman 212-697-6484 firstname.lastname@example.org
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts